These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17470831)

  • 21. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
    Maini R; St Clair EW; Breedveld F; Furst D; Kalden J; Weisman M; Smolen J; Emery P; Harriman G; Feldmann M; Lipsky P
    Lancet; 1999 Dec; 354(9194):1932-9. PubMed ID: 10622295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
    Muratore F; Pipitone N; Hunder GG; Salvarani C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
    Lally L; Forbess L; Hatzis C; Spiera R
    Arthritis Rheumatol; 2016 Oct; 68(10):2550-4. PubMed ID: 27159185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial.
    Saraux A; Le Henaff C; Dernis E; Carvajal-Alegria G; Tison A; Quere B; Petit H; Felten R; Jousse-Joulin S; Guellec D; Marhadour T; Kervarrec P; Cornec D; Querellou S; Nowak E; Souki A; Devauchelle-Pensec V
    Lancet Rheumatol; 2023 Dec; 5(12):e728-e735. PubMed ID: 38251563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study.
    Littman BH; Bjarnason D; Bryant G; Engelbrecht J; Cohen M; Mertz L; Weaver A; Hunder GG
    J Rheumatol; 1995 Jun; 22(6):1097-103. PubMed ID: 7674236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials.
    Song GG; Lee YH
    Int J Clin Pharmacol Ther; 2021 May; 59(5):366-371. PubMed ID: 33480843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis.
    Ann Intern Med; 2007 May; 146(9):I12. PubMed ID: 17470826
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature.
    Aikawa NE; Pereira RM; Lage L; Bonfá E; Carvalho JF
    Clin Rheumatol; 2012 Mar; 31(3):575-9. PubMed ID: 22234490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.
    Klarenbeek NB; Güler-Yüksel M; van der Kooij SM; Han KH; Ronday HK; Kerstens PJ; Seys PE; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Jun; 70(6):1039-46. PubMed ID: 21415052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
    Giollo A; Rossini M; Bettili F; Ghellere F; Fracassi E; Idolazzi L; Gatti D; Viapiana O
    J Rheumatol; 2019 Mar; 46(3):318-322. PubMed ID: 30385701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S126-35. PubMed ID: 18240203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
    Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E
    J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biologicals in the treatment of rheumatic diseases].
    Scherer HU; Burmester GR
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
    Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.